• Latest Posts

Servier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

More News! 19 Sep 2018

This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity Testing

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology

Servier offers up to €1.7B for Dual Cancer Checkpoint Inhibitors

The 10 Biggest Clinical Success Stories of 2016 in European Biotech


Cellectis gets paid for a first Milestone, Investors are pleased

EU approves Combo-Drug for Metastatic Colorectal Cancer

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

How Good was 2015 for the French Universal CAR-T Biotech?

Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?